CoChat

Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France

Denis, Blandine, Guiguet, Marguerite, de Castro, Nathalie, Mechaï, Frédéric, Revest, Matthieu, Melica, Giovanna, Costagliola, Dominique, Lortholary, Olivier · 2015 · Clinical Infectious Diseases

The DOI matches its Crossref record, with a small difference in title or year; 13 of the 13 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Before the advent of combination antiretroviral therapy (cART), roughly 50% of cases of invasive aspergillosis (IA) associated with human immunodeficiency virus (HIV) infection involved individuals without classical predisposing host factors, and the median survival time was <4 months after diagnosis. We examined if the situation evolved over time using the revised European Organisation for Research and Treatment of Cancer/National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC) definition and analyzed survival trends after diagnosis over 20 years. METHODS: A data review committee evaluated 342 medical records that mentioned IA in the French Hospital Database on HIV. Validated cases were classified as fulfilling the EORTC criteria or otherwise as "HIV-related IA." Three periods were analyzed: pre-cART (before 1996), cART era prevoriconazole (1996-2001), and 2002-2011. RESULTS: Among 242 validated cases of IA, 124 (51%) fulfilled the EORTC criteria (EORTC-IA) and 118 (49%) were classified as "HIV-related," with similarly low CD4 cell counts in both groups. The proportion of EORTC-IA cases remained stable across the 3 periods (50%, 48%, and 54%, respectively). The 3-month survival rate improved after the advent of cART (38% vs 69%), with no difference between EORTC-IA and HIV-related IA (hazard ratio [HR], 1.2 95% confidence interval [CI] {0.7-1.8}). Voriconazole exposure decreased mortality in 2002-2011 (HR, 0.1 95% CI [0.01-0.8]). CONCLUSIONS: In the cART era, EORTC criteria, developed for use in hematology/oncology, still applied to only half the cases diagnosed among HIV-infected patients. A rapid diagnosis of IA is paramount to improve survival. For patients who do not fulfill the EORTC definition, we suggest that the addition of "HIV infected with a CD4 count <100 cells/µL" to the EORTC host criteria be validated.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/civ492

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Denis, B., Guiguet, M., de Castro, N., Mechaï, F., Revest, M., Melica, G., Costagliola, D., & Lortholary, O.
Affiliations
  • Inserm (FR)
  • Centre Hospitalier Universitaire de Rennes (FR)
  • Centre Hospitalier Universitaire Henri-Mondor (FR)
  • Sorbonne Université (FR)
  • Hôpital Necker-Enfants Malades (FR)
Corresponding author
Denis, Blandine
Venue
Clinical Infectious Diseases
Published
2015-06-29
Volume
61
Issue
8
Pages
1273-1280
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2205816243
Cited by
33
References
13
Citations by year
2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 3
FWCI
2.85
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Agence Nationale de Recherche sur le SIDA et les hépatites virales
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
invasive aspergillosis, HIV infection, EORTC criteria, diagnostic criteria, survival trends, highly active antiretroviral therapy, voriconazole, CD4 count, opportunistic fungal infection
MeSH terms
Adult, Antifungal Agents, Aspergillosis, Aspergillus, Drug Therapy, Combination, Female, France, Humans, Male, Medical Records, Middle Aged, Time Factors, HIV Infections, Survival Rate, Proportional Hazards Models, CD4 Lymphocyte Count, Anti-HIV Agents, Invasive Pulmonary Aspergillosis, Voriconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.